TXG – 10x genomics, inc. (US:NASDAQ)

News

Spatial Genomics and Transcriptomics Research Analysis Report 2024-2030: Emergence of High-Throughput Sequencing Platforms Fuels Market Growth [Yahoo! Finance]
Sphere Fluidics Strengthens Global Commercial Teams and Establishes Direct Sales and Support Channel in North America [Yahoo! Finance]
10x Genomics to Present at the Wolfe Research 2024 Healthcare Conference
10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $21.00 to $19.00. They now have an "overweight" rating on the stock.
Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com